These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 1731040

  • 1. Effect of long-acting calcium entry blocker (anipamil) on blood pressure, renal function and survival of uremic rats.
    Jarusiripipat C, Chan L, Shapiro JI, Schrier RW.
    J Pharmacol Exp Ther; 1992 Jan; 260(1):243-7. PubMed ID: 1731040
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M, Rodrigue ME, Agharazii M, Larivière R.
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [Abstract] [Full Text] [Related]

  • 3. The control of hypertension and its effect on renal function in rat remnant kidney.
    Eliahou HE, Cohen D, Herzog D, Shechter P, Serban I, Kapuler S, Schiby G, Gavendo S.
    Nephrol Dial Transplant; 1988 Dec; 3(1):38-44. PubMed ID: 3132638
    [Abstract] [Full Text] [Related]

  • 4. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T, Honda T, Ohta S, Akashiba A, Takahashi T, Kameda T, Yoshii M, Minami J, Takahashi M, Ono H, Matsuoka H.
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [Abstract] [Full Text] [Related]

  • 5. Long acting calcium antagonist anipamil limits myocardial necrosis and penetrates the ischemic zone during 24 h of coronary artery occlusion in the dog.
    Denniss AR, Kingma JG, Hearse DJ, Downey JM, Yellon DM.
    Can J Cardiol; 1990 Dec; 6(1):31-7. PubMed ID: 2310993
    [Abstract] [Full Text] [Related]

  • 6. In vivo anti-platelet properties of anipamil, a calcium channel blocker, in the rabbit.
    Osborne JA, Darius H, Lefer AM.
    Res Commun Chem Pathol Pharmacol; 1986 May; 52(2):167-78. PubMed ID: 3715198
    [Abstract] [Full Text] [Related]

  • 7. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [Abstract] [Full Text] [Related]

  • 8. Comparative effects of captopril and enalapril on the progression of chronic renal disease in partially nephrectomized rats.
    Fettman MJ, Wilke WL, VanHouten DS, Hamar DW, Mikita DJ.
    Res Commun Chem Pathol Pharmacol; 1989 Aug; 65(2):131-46. PubMed ID: 2555851
    [Abstract] [Full Text] [Related]

  • 9. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
    [Abstract] [Full Text] [Related]

  • 10. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 11. Effect of pretreatment with anipamil on a submaximal calcium paradox in the isolated rat heart.
    Ruigrok TJ, Kirkels JH.
    Cardioscience; 1990 Sep; 1(3):213-6. PubMed ID: 2102810
    [Abstract] [Full Text] [Related]

  • 12. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
    Jackson B, Cubela R, Debrevi L, Whitty M, Johnston CI.
    J Cardiovasc Pharmacol; 1987 Sep; 10 Suppl 10():S167-9. PubMed ID: 2455124
    [Abstract] [Full Text] [Related]

  • 13. Effects of probucol in renal function and structure in rats with subtotal kidney ablation.
    Modi KS, Schreiner GF, Purkerson ML, Klahr S.
    J Lab Clin Med; 1992 Aug; 120(2):310-7. PubMed ID: 1500828
    [Abstract] [Full Text] [Related]

  • 14. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

  • 15. Cardioprotective actions of a new calcium channel blocker in acute myocardial ischemia.
    Brezinski ME, Darius H, Lefer AM.
    Arzneimittelforschung; 1986 Mar; 36(3):464-6. PubMed ID: 3707665
    [Abstract] [Full Text] [Related]

  • 16. Effects of protease therapy in the remnant kidney model of progressive renal failure.
    Sebekova K, Paczek L, Dämmrich J, Ling H, Spustova V, Gaciong Z, Heidland A.
    Miner Electrolyte Metab; 1997 Mar; 23(3-6):291-5. PubMed ID: 9387136
    [Abstract] [Full Text] [Related]

  • 17. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A.
    Ann Acad Med Stetin; 1999 Mar; Suppl 52():1-93. PubMed ID: 10589103
    [Abstract] [Full Text] [Related]

  • 18. [Are all antihypertensive drugs renoprotective?].
    Wolf S, Risler T.
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [Abstract] [Full Text] [Related]

  • 19. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D.
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [Abstract] [Full Text] [Related]

  • 20. Effects of chronic administration of somatostatin analogue SMS 201-995 on the progression of chronic renal failure in subtotal nephrectomized rats.
    Uemasu J, Tokumoto A, Godai K, Kawasaki H, Hirayama C.
    Exp Clin Endocrinol; 1990 Sep; 96(1):97-104. PubMed ID: 2279532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.